| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2bfd9c2c1decf731d6409d54652793e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43 |
| filingDate |
2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe9de16c42d5e04b91a7c0955ac6e3e |
| publicationDate |
2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011152806-A1 |
| titleOfInvention |
Production method for the effervescent formulation comprising cephalosporin and potassium clavulanate |
| abstract |
The present invention relates to the process for the preparation of effervescent pharmaceutical formulations comprising cephalosporin antibiotic and clavulanic acid or any pharmaceutically acceptable derivative thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013109225-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2815743-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10624899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018013870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109715156-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014057059-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013109201-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012060788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014065769-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014174405-A1 |
| priorityDate |
2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |